{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:47:59Z","timestamp":1790808479653,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.transci.2020.102826","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T11:44:00Z","timestamp":1591098240000},"page":"102826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Preoperative plasmapheresis experience in Graves\u2019 disease patients with anti-thyroid drug-induced hepatotoxicity"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-8669","authenticated-orcid":false,"given":"Tugce","family":"Apayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8580-9471","authenticated-orcid":false,"given":"Onur","family":"Elbasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6313","authenticated-orcid":false,"given":"Dilek Gogas","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2020.102826_bib0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.10295","article-title":"Neutropenia and agranulocytosis in England and Wales: incidence and risk factors","volume":"72","author":"van Staa","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2020.102826_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1572-0241.2001.03469.x","article-title":"The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study","volume":"96","author":"Kim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transci.2020.102826_bib0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil Cytoplasmic Antibody-Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?","volume":"25","author":"Balavoine","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.transci.2020.102826_bib0020","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4158\/EP09265.CR","article-title":"Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis","volume":"16","author":"Vyas","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/j.transci.2020.102826_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/thy.2011.0210","article-title":"Acute pancreatitis induced by methimazole in a patient with Graves' disease","volume":"22","author":"Yang","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.transci.2020.102826_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3803\/EnM.2013.28.1.55","article-title":"Two cases of methimazole-induced insulin autoimmune syndrome in graves\u2019 disease","volume":"28","author":"Roh","year":"2013","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.transci.2020.102826_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/thy.2014.0350","article-title":"Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China","volume":"25","author":"Yang","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.transci.2020.102826_bib0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-118-6-199303150-00005","article-title":"Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study","volume":"118","author":"Liaw","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2020.102826_bib0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2020.102826_bib0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ecl.2006.09.008","article-title":"Thyrotoxicosis and thyroid storm","volume":"35","author":"Nayak","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.transci.2020.102826_bib0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"17","author":"Bahn","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.transci.2020.102826_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the american society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102826_bib0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","author":"Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.transci.2020.102826_bib0070","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.1970.03180070041007","article-title":"Thyroid storm treatment with blood exchange and plasmapheresis","volume":"214","author":"Ashkar","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2020.102826_bib0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jca.20200","article-title":"Preoperative therapeutic plasma exchange in patients with thyrotoxicosis","volume":"24","author":"Ezer","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102826_bib0080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1368-5031.2004.00140.x","article-title":"Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated","volume":"58","author":"Ozbey","year":"2004","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.transci.2020.102826_bib0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jca.1026","article-title":"Coagulation abnormalities in serial double-filtration plasmapheresis","volume":"16","author":"Yeh","year":"2001","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102826_bib0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/jca.2920030209","article-title":"The effect of serial therapeutic plasmapheresis on platelet count, coagulation factors, plasma immunoglobulin, and complement levels","volume":"3","author":"Wood","year":"1986","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2020.102826_bib0095","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.V56.6.1055.1055","article-title":"Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents","volume":"56","author":"Orlin","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.transci.2020.102826_bib0100","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1182\/blood.V54.3.694.694","article-title":"The hemostatic imbalance of plasma-exchange transfusion","volume":"54","author":"Flaum","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.transci.2020.102826_bib0105","series-title":"Choosing wisely","author":"Foundation A","year":"2018"},{"key":"10.1016\/j.transci.2020.102826_bib0110","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jca.21653","article-title":"Hemostasis management and therapeutic plasma exchange: results of a practice survey","volume":"33","author":"Zantek","year":"2018","journal-title":"J Clin Apher"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022030121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022030121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:55Z","timestamp":1761468715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022030121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S147305022030121X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102826","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative plasmapheresis experience in Graves\u2019 disease patients with anti-thyroid drug-induced hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102826"}}